Myopathy as a first symptom of Huntington’s disease in a marathon runner (Summary by Justo García de Yébenes)
Christoph Kosinski et al.
am01-feb2008-issue01-en 

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul Gordon et al.
am02-feb2008-issue01-en 

Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease
Sung-Rae Cho et al.
am03-feb2008-issue01-en 

Effects of an intensive rehabilitation programme on patients with Huntington’s disease: a pilot study
Paola Zinzi et al.
am04-jun2008-issue02-en 

Riluzole in Huntington’s disease: a 3-year, randomized controlled study
G. Bernhard Landwehrmeyer et al.
am05-jun2008-issue02-en 

Huntingtin interacting proteins are genetic modifiers of neurodegeneration
Linda S. Kaltenbach et al.
am06-jun2008-issue02-en 

Hand tapping: A simple, reproducible, objective marker of motor dysfunction in Huntington’s disease
Andrew W. Michell et al.
am07-sep2008-issue03-en 

Rapid eye movement sleep disturbances in Huntington Disease
Isabelle Arnulf et al.
am08-sep2008-issue03-en 

Identification and allele-specific silencing of the mutant huntingtin allele in Huntington’s disease patient-derived fibroblasts
Paul H. J. van Bilsen et al.
am09-sep2008-issue03-en 

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease (Summary by Ed Wild)
Maria Björkqvist, Edward Wild et al.
am10-dec2008-issue04-en 

Long-term outcome of presymptomatic testing in Huntington disease
Marcela Gargiulo, Séverine Lejeune et al.
am11-dec2008-issue04-en 

Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
am12-dec2008-issue04-en